Skip to main content
Signal8
Bagley Bowman profile photo

Bowman Bagley

CIK: 0002117210

Transaction Breakdown

Open Market Buys (P)0

High conviction signal

Open Market Sales (S)0

Position reduction

Option Exercises (M)0

Derivative conversions

Awards (A)0

Compensation grants

Other (G, F, J, C, D, …)0

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CollPlant Biotechnologies Ltd logo
CLGN

CollPlant Biotechnologies Ltd

Officer

Discretionary Trading P&L

Holdings

Transaction History (0 total)

1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.

0-0 of 0

Bowman Bagley files insider reports with the SEC as VP Commercial North America of CollPlant Biotechnologies Ltd (CLGN).

About Bagley Bowman

Bagley Bowman (SEC CIK 0002117210) files insider reports with the SEC as VP Commercial North America of CollPlant Biotechnologies Ltd (CLGN).

Signal8 holds 1 ownership filing by Bagley Bowman, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.

The business address on Bagley Bowman's filings is in REHOVOT.

Other insiders filing for CollPlant Biotechnologies Ltd (CLGN)

How to read Form 4 transaction codes